| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +38,475 | 18% | $8.07 | +$310,319 |
| Sells | 5 | -176,363 | 82% | $9.39 | -$1,655,859 |
| Net | -1 | -137,888 | -64% | -$1,345,541 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Neil F. McFarlane | ZVRA | Common Stock | Sale | -3.64% | $125,186 | $8.56 | -14,625 | 387,225 | 09 Feb 2026 | Direct |
| Neil F. McFarlane | ZVRA | Common Stock | Options Exercise | 10.3% | 37,500 | 401,850 | 07 Feb 2026 | Direct | ||
| Neil F. McFarlane | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -37,500 | 75,000 | 07 Feb 2026 | Direct | ||
| Joshua Schafer | ZVRA | Common Stock | Sale | -14.4% | $96,500 | $9.19 | -10,500 | 62,278 | 03 Feb 2026 | Direct |
| Timothy J. Sangiovanni | ZVRA | Common Stock | Sale | -9.21% | $27,548 | $9.18 | -3,000 | 29,590 | 03 Feb 2026 | Direct |
| Neil F. McFarlane | ZVRA | Common Stock | Sale | -20% | $853,425 | $9.38 | -91,000 | 364,350 | 02 Feb 2026 | Direct |
| Joshua Schafer | ZVRA | Common Stock | Options Exercise | 94.4% | 35,334 | 72,778 | 31 Jan 2026 | Direct | ||
| Joshua Schafer | ZVRA | Restricted Stock Unit | Options Exercise | -50% | -35,334 | 35,333 | 31 Jan 2026 | Direct | ||
| Timothy J. Sangiovanni | ZVRA | Common Stock | Options Exercise | 55.8% | 11,666 | 32,590 | 31 Jan 2026 | Direct | ||
| Timothy J. Sangiovanni | ZVRA | Restricted Stock Unit | Options Exercise | -50% | -11,666 | 11,668 | 31 Jan 2026 | Direct | ||
| Neil F. McFarlane | ZVRA | Common Stock | Options Exercise | 105.1% | 233,334 | 455,350 | 31 Jan 2026 | Direct | ||
| Neil F. McFarlane | ZVRA | Restricted Stock Unit | Options Exercise | -50% | -233,334 | 233,333 | 31 Jan 2026 | Direct | ||
| Joshua Schafer | ZVRA | Common Stock | Sale | -8.27% | $29,800 | $8.83 | -3,375 | 37,444 | 30 Jan 2026 | Direct |
| Joshua Schafer | ZVRA | Common Stock | Options Exercise | 38.4% | 11,333 | 40,819 | 30 Jan 2026 | Direct | ||
| Joshua Schafer | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -11,333 | 22,667 | 30 Jan 2026 | Direct | ||
| Adrian W. Quartel | ZVRA | Common Stock | Sale | -31.8% | $40,036 | $8.83 | -4,533 | 9,723 | 30 Jan 2026 | Direct |
| Adrian W. Quartel | ZVRA | Common Stock | Options Exercise | 387.7% | 11,333 | 14,256 | 30 Jan 2026 | Direct | ||
| Adrian W. Quartel | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -11,333 | 22,667 | 30 Jan 2026 | Direct | ||
| Rahsaan Thompson | ZVRA | Common Stock | Sale | -7.56% | $36,010 | $8.83 | -4,080 | 49,919 | 30 Jan 2026 | Direct |
| Rahsaan Thompson | ZVRA | Common Stock | Options Exercise | 26.6% | 11,333 | 53,999 | 30 Jan 2026 | Direct | ||
| Rahsaan Thompson | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -11,333 | 22,667 | 30 Jan 2026 | Direct | ||
| Timothy J. Sangiovanni | ZVRA | Common Stock | Sale | -7.72% | $15,442 | $8.82 | -1,750 | 20,924 | 30 Jan 2026 | Direct |
| Timothy J. Sangiovanni | ZVRA | Common Stock | Options Exercise | 38.8% | 6,333 | 22,674 | 30 Jan 2026 | Direct | ||
| Timothy J. Sangiovanni | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -6,333 | 12,667 | 30 Jan 2026 | Direct | ||
| Joshua Schafer | ZVRA | Stock Option (right to buy) | Award | 75,000 | 75,000 | 29 Jan 2026 | Direct | |||
| Joshua Schafer | ZVRA | Restricted Stock Unit | Award | 37,500 | 37,500 | 29 Jan 2026 | Direct | |||
| Adrian W. Quartel | ZVRA | Stock Option (right to buy) | Award | 75,000 | 75,000 | 29 Jan 2026 | Direct | |||
| Adrian W. Quartel | ZVRA | Restricted Stock Unit | Award | 37,500 | 37,500 | 29 Jan 2026 | Direct | |||
| Rahsaan Thompson | ZVRA | Stock Option (right to buy) | Award | 75,000 | 75,000 | 29 Jan 2026 | Direct | |||
| Rahsaan Thompson | ZVRA | Restricted Stock Unit | Award | 37,500 | 37,500 | 29 Jan 2026 | Direct | |||
| Neil F. McFarlane | ZVRA | Stock Option (right to buy) | Award | 250,000 | 250,000 | 29 Jan 2026 | Direct | |||
| Neil F. McFarlane | ZVRA | Restricted Stock Unit | Award | 125,000 | 125,000 | 29 Jan 2026 | Direct | |||
| R. LaDuane Clifton | ZVRA | Common Stock | Tax liability | -25.3% | -48,513 | 143,515 | 31 Dec 2025 | Direct | ||
| R. LaDuane Clifton | ZVRA | Common Stock | Options Exercise | 273.9% | 140,667 | 192,028 | 31 Dec 2025 | Direct | ||
| R. LaDuane Clifton | ZVRA | Performance Stock Unit | Options Exercise | -100% | -20,000 | 0 | 31 Dec 2025 | Direct | ||
| R. LaDuane Clifton | ZVRA | Restricted Stock Unit | Options Exercise | -100% | -120,667 | 0 | 31 Dec 2025 | Direct | ||
| Alicia Secor | ZVRA | Stock Option (right to buy) | Award | 45,000 | 45,000 | 02 Dec 2025 | Direct | |||
| Neil F. McFarlane | ZVRA | Common Stock | Sale | -8.07% | $210,908 | $10.82 | -19,500 | 222,016 | 10 Oct 2025 | Direct |
| Neil F. McFarlane | ZVRA | Common Stock | Options Exercise | 26.1% | 50,000 | 241,516 | 10 Oct 2025 | Direct | ||
| Neil F. McFarlane | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -50,000 | 100,000 | 10 Oct 2025 | Direct | ||
| TAMARA A. FAVORITO | ZVRA | Common Stock | Purchase | 441.6% | $24,718 | $7.79 | 3,175 | 3,894 | 12 Sep 2025 | Direct |
| Alvin Shih | ZVRA | Common Stock | Purchase | $157,800 | $7.89 | 20,000 | 20,000 | 12 Sep 2025 | Direct | |
| John B. Bode | ZVRA | Common Stock | Purchase | 12.5% | $45,825 | $9.16 | 5,000 | 45,000 | 19 Aug 2025 | Direct |
| Rahsaan Thompson | ZVRA | Common Stock | Sale | -36% | $221,004 | $9.21 | -24,000 | 42,666 | 26 Jun 2025 | Direct |
| Rahsaan Thompson | ZVRA | Common Stock | Options Exercise | 66,666 | 66,666 | 21 Jun 2025 | Direct | |||
| Rahsaan Thompson | ZVRA | Restricted Stock Unit | Options Exercise | -33.3% | -66,666 | 133,334 | 21 Jun 2025 | Direct | ||
| Alvin Shih | ZVRA | Stock Option (right to buy) | Award | 30,000 | 30,000 | 29 May 2025 | Direct | |||
| WENDY L. DIXON | ZVRA | Stock Option (right to buy) | Award | 30,000 | 30,000 | 29 May 2025 | Direct | |||
| Douglas W. Calder | ZVRA | Stock Option (right to buy) | Award | 30,000 | 30,000 | 29 May 2025 | Direct | |||
| TAMARA A. FAVORITO | ZVRA | Stock Option (right to buy) | Award | 30,000 | 30,000 | 29 May 2025 | Direct |